Novel Three-Drug Combinations of Bortezomib, Thalidomide, Dexamethasone and Lenalidomide for Newly Diagnosed Multiple Myeloma (MM)
Submitted by web@researchtop... on Fri, 07/09/2010 - 12:09
5-Minute Journal Club — ASCO 2010 Presentations
Submitted by web@researchtop... on Fri, 07/09/2010 - 11:47
5-Minute Journal Club — ASCO 2010 Presentations
Submitted by web@researchtop... on Wed, 07/07/2010 - 15:09
Lenalidomide as Initial Treatment for Elderly Patients with Chronic Lymphocytic Leukemia (CLL)
Submitted by jwr@option4.com on Wed, 07/07/2010 - 14:33
Complete Response Rates with Lenalidomide/Rituximab in the Front-Line Treatment of Indolent B-Cell Non-Hodgkin Lymphoma (NHL)
Submitted by jwr@option4.com on Wed, 07/07/2010 - 14:21
In Vivo Purging with Rituximab Before Stem Cell Collection and Maintenance Rituximab After Transplant for Patients with Relapsed Follicular Lymphoma (FL)
Submitted by jwr@option4.com on Wed, 07/07/2010 - 14:13
Maintenance Rituximab for Patients with Follicular Lymphoma (FL) Responding to Front-Line Induction with Rituximab/Chemotherapy
Submitted by jwr@option4.com on Wed, 07/07/2010 - 13:57
HR Form | Publishing/Production Traffic Administrator Resume Submission Form
Please take a moment for fill out the attached questionnaire before submitting your resume and/or cover letter.
5-Minute Journal Club — ASCO 2010 Presentations
Submitted by web@researchtop... on Tue, 07/06/2010 - 10:15
5-Minute Journal Club — ASCO 2010 Presentations |
|---|
B-raf Kinase Inhibitor GSK2118436 as Therapy for Patients with Metastatic Melanoma and Other Solid Tumors
Submitted by web@researchtop... on Sat, 07/03/2010 - 08:43
Ipilimumab Monotherapy for Patients with Melanoma and Brain Metastases
Submitted by web@researchtop... on Sat, 07/03/2010 - 08:35
Ipilimumab or the gp100 Vaccine or the Combination of Both as Therapy for Patients with Metastatic Melanoma
Submitted by web@researchtop... on Sat, 07/03/2010 - 08:22
5-Minute Journal Club — ASCO 2010 Presentations
Submitted by web@researchtop... on Wed, 06/30/2010 - 10:47
5-Minute Journal Club — ASCO 2010 Presentations |
|---|
Bevacizumab in the Primary Treatment of Advanced Ovarian, Peritoneal or Fallopian Tube Carcinoma
Submitted by web@researchtop... on Tue, 06/29/2010 - 11:45
AMG 386, an Angiogenesis Inhibitor, in the Treatment of Recurrent Ovarian, Peritoneal or Fallopian Tube Carcinoma
Submitted by web@researchtop... on Mon, 06/28/2010 - 17:57